Randall Moreadith insider trades: Serina Therapeutics (SER) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Randall reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | SER | ↓ Sell | 6,500 | $2.86 | $19K | Direct | Mar 24, 2026 (1d) |
| Mar 19, 2026 | SER | ↓ Sell | 39,000 | $2.50 | $98K | Direct | Mar 20, 2026 (1d) |
| Feb 2, 2026 | SER | ↓ Sell | 6,500 | $3.03 | $20K | Direct | Feb 3, 2026 (1d) |
| Jan 28, 2026 | SER | ↓ Sell | 6,500 | $3.57 | $23K | Direct | Jan 29, 2026 (1d) |
| Jan 22, 2026 | SER | ↓ Sell | 2,500 | $2.95 | $7K | Direct | Jan 23, 2026 (1d) |
| Jan 21, 2026 | SER | ↓ Sell | 4,000 | $3.04 | $12K | Direct | Jan 21, 2026 (0d) |
| Jan 14, 2026 | SER | ↓ Sell | 6,500 | $2.50 | $16K | Direct | Jan 14, 2026 (0d) |
| Jan 8, 2026 | SER | ↓ Sell | 13,000 | $2.69 | $35K | Direct | Jan 9, 2026 (1d) |
| Dec 22, 2025 | SER | ↓ Sell | 5,673 | $2.67 | $15K | Direct | Dec 23, 2025 (1d) |
| Dec 16, 2025 | SER | ↓ Sell | 3,227 | $2.96 | $10K | Direct | Dec 17, 2025 (1d) |
| Dec 12, 2025 | SER | ↓ Sell | 1,700 | $3.26 | $6K | Direct | Dec 16, 2025 (4d) |
| Dec 11, 2025 | SER | ↓ Sell | 3,555 | $3.24 | $12K | Direct | Dec 12, 2025 (1d) |
| Dec 10, 2025 | SER | ↓ Sell | 1,245 | $3.33 | $4K | Direct | Dec 11, 2025 (1d) |
| Dec 3, 2025 | SER | ↓ Sell | 6,500 | $3.61 | $23K | Direct | Dec 4, 2025 (1d) |
| Nov 25, 2025 | SER | ↓ Sell | 5,965 | $3.90 | $23K | Direct | Nov 26, 2025 (1d) |
| Nov 24, 2025 | SER | ↓ Sell | 535 | $3.93 | $2K | Direct | Nov 25, 2025 (1d) |
| Nov 18, 2025 | SER | ↓ Sell | 6,500 | $3.75 | $24K | Direct | Nov 19, 2025 (1d) |
| Nov 10, 2025 | SER | ↓ Sell | 6,500 | $4.10 | $27K | Direct | Nov 12, 2025 (2d) |
| Nov 5, 2025 | SER | ↓ Sell | 3,398 | $4.24 | $14K | Direct | Nov 6, 2025 (1d) |
| Nov 4, 2025 | SER | ↓ Sell | 3,102 | $4.40 | $14K | Direct | Nov 5, 2025 (1d) |
| Oct 28, 2025 | SER | ↓ Sell | 5,551 | $4.96 | $28K | Direct | Oct 29, 2025 (1d) |
| Oct 27, 2025 | SER | ↓ Sell | 949 | $5.19 | $5K | Direct | Oct 28, 2025 (1d) |
| Oct 20, 2025 | SER | ↓ Sell | 6,500 | $4.97 | $32K | Direct | Oct 21, 2025 (1d) |
| Oct 13, 2025 | SER | ↓ Sell | 4,326 | $5.20 | $22K | Direct | Oct 14, 2025 (1d) |
| Aug 26, 2025 | SER | ↓ Sell | 47,674 | $6.95 | $331K | Direct | Aug 27, 2025 (1d) |
| Aug 20, 2025 | SER | ↓ Sell | 4,304 | $5.18 | $22K | Direct | Aug 20, 2025 (0d) |
| Aug 12, 2025 | SER | ↓ Sell | 5,500 | $5.25 | $29K | Direct | Aug 14, 2025 (2d) |
| Aug 4, 2025 | SER | ↓ Sell | 5,500 | $5.17 | $28K | Direct | Aug 6, 2025 (2d) |
| Jul 29, 2025 | SER | ↓ Sell | 4,196 | $6.50 | $27K | Direct | Jul 30, 2025 (1d) |
| Jul 28, 2025 | SER | ↓ Sell | 6,500 | $5.89 | $38K | Direct | Jul 29, 2025 (1d) |
| Jul 21, 2025 | SER | ↓ Sell | 6,500 | $5.34 | $35K | Direct | Jul 22, 2025 (1d) |
| Jul 14, 2025 | SER | ↓ Sell | 6,500 | $5.01 | $33K | Direct | Jul 17, 2025 (3d) |
| Jul 7, 2025 | SER | ↓ Sell | 6,500 | $5.67 | $37K | Direct | Jul 9, 2025 (2d) |
| Jun 30, 2025 | SER | ↓ Sell | 6,500 | $5.78 | $38K | Direct | Jul 2, 2025 (2d) |
| Nov 10, 2005 | RNVS | ↓ Sell10b5-1 | 1,000 | $13.66 | $14K | Direct | Nov 14, 2005 (4d) |
| Oct 10, 2005 | RNVS | ↓ Sell10b5-1 | 1,000 | $13.43 | $13K | Direct | Oct 11, 2005 (1d) |
| Sep 12, 2005 | RNVS | ↓ Sell10b5-1 | 1,000 | $14.20 | $14K | Direct | Sep 14, 2005 (2d) |
| Aug 10, 2005 | RNVS | ↓ Sell10b5-1 | 1,000 | $13.30 | $13K | Direct | Aug 12, 2005 (2d) |
| Jun 15, 2005 | RNVS | ↓ Sell | 5,400 | $13.35 | $72K | Direct | Jun 17, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SER insiders
Open-market trades in the last 12 months
About Randall Moreadith's insider trades
Randall Moreadith is Chief Scientific Officer at Serina Therapeutics (SER). Since Jun 15, 2005, Randall has reported no open-market purchases and 39 sales worth $1.2M on SEC Form 4. In the last 12 months: 18 sales ($375K).
4 sales (4% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (38 filings), grants and awards (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SER insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.